Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study
Abstract Introduction The introduction of clacitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) has revolutionized the treatment of migraines. In clinical practice gepants might be considered as a valid option to treat acute attacks in patients with migraine who are treated with mAbs....
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Adis, Springer Healthcare
2024-02-01
|
| Serija: | Neurology and Therapy |
| Teme: | |
| Online pristup: | https://doi.org/10.1007/s40120-024-00586-w |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|